Cynata Therapeutics Ltd V.CYP

Primary Symbol: CYYNF

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.

OTCPK:CYYNF - Post by User

Cynata Therapeutics Ltd > Sold

<< Previous

Bullboard Posts

Next >>

Comment by got2winon Feb 08, 2021 11:52am

109 Views

Post# 32501160

RE:Sold

Nopoo inferred on Jan 21st insiders were selling tens of thousands of shares,, as a result he sold a considerable number of shares.
The fact is insiders have sold NO shares, I checked Canadian Insider this morning and there are no transactions since Oct. 5th, an excersise of warrants. Canadian Insider does of a short delay in updating their site. But I think 18 days is more than enough time for the update to have occurred, if there was an update.

<< Previous

Bullboard Posts

Next >>

Retail giant Walmart Canada celebrates 30 years of business